Anticancer agent 87
Anticancer agent 87 is a spirooxindole-furan derivative with anticancer activity. Anticancer agent 87 can be used for the research of breast adenocarcinoma and human liver cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C30H21BrCl2N2O3S
- Peso molecular:640.37
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
Descripciòn
In Vitro
Anticancer agent 87 (Compound 6f) potently inhibits the viability of MCF7 breast adenocarcinoma cells with an IC50 of 10.3 μM/mL[1].
Anticancer agent 87 potently inhibits the viability of HepG2 liver carcinoma cells with an IC50 of 3.5 μM/mL[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Peso molecular 640.37
-
Fòrmula C30H21BrCl2N2O3S
-
SMILES
O=C1NC2=C(C=CC(Cl)=C2)[C@@]13N4CSCC4[C@@H](C5=CC=C(C6=CC=CC=C6Cl)O5)[C@@H]3C(C7=CC=C(Br)C=C7)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Anticancer agent 87 Related Classifications
HY-151570 Related Classifications
Powered by Bioz